Archive for July, 2008
« Previous Entries Next Entries »Study Shows Promising Results In Deep Brain Stimulation For Treatment-Resistant Depression
Tuesday, July 22nd, 2008New data from a study of patients with treatment-resistant depression who underwent deep brain stimulation (DBS) in the subcallosal cingulate region (SCG or Cg25) of the brain shows that this intervention is generally safe and provides significant improvement in patients as early as one month after treatment. The patients also experienced continued and sustained improvement […]
PTSD Influences Levels Of Depression And Pain
Tuesday, July 22nd, 2008Patients with accident or trauma related chronic pain often have post-traumatic stress disorder (PTSD) and depression. What isn’t clearly known, however, is how PTSD relates to mood disorders and pain severity in chronic pain patients. University of Michigan researchers examined the contribution of PTSD to the pain experience, functional disability and frequency […]
NY Health Department Launches MySpace Campaign To Help Young New Yorkers Cope
Tuesday, July 22nd, 2008The Health Department today announced a new online campaign to engage teenagers grappling with depression, drugs, and violence, and to encourage them to seek help. NYC Teen Mindspace, posted on MySpace, is the agency’s first effort to promote health through Web-based social networking - a medium with great potential because of its popularity […]
Treating Depression Reduces Risk Of Heart Disease
Saturday, July 19th, 2008Patients suffering from major depression are at an increased risk for cardiovascular disease, but treating these patients with medication can greatly reduce the risk, according to new findings by researchers at the University of Miami Miller School of Medicine. The results of their study are published in the July 16 issue of the journal […]
Easing The Pain Of Diabetes - Dying A Depression Drug For Common Nerve Condition
Wednesday, July 16th, 2008To ease pain and numbness associated with diabetes, NewYork-Presbyterian/Weill Cornell physician-scientists are studying a drug previously used for depression to treat peripheral neuropathy. Diabetics often suffer from this condition because of high blood sugar levels that damage nerve cells. Those with peripheral neuropathy often endure chronic pain, cramping and sleepless nights that prevent them from […]
Current And Emerging Drugs Continue To Struggle For Patient Share In The Treatment Of Major Depressive Disorder
Wednesday, July 16th, 2008Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug’s long-term efficacy in preventing recurrence of depressive mood episodes in patients who suffer from major depressive disorder, is the attribute that most influences psychiatrists’ […]
Depression And Antidepressants Increase Risk Of Falling In Later Life
Wednesday, July 16th, 2008Depression And Antidepressants Increase Risk Of Falling In Later Life Older people have a high risk for falls and the ensuing injuries. This risk, according to an article released on June 17, 2008 in the open-access journal PLoS ONE, is increased by the presence of depression, and increased even […]
Culture And Depression - New Data May Help Doctors More Accurately Diagnose Patients
Tuesday, July 15th, 2008The expectation that East-Asian people emphasize physical symptoms of depression (e.g. headaches, poor appetite or aches/pains in the body) is widely acknowledged, yet the few available empirical studies report mixed data on this issue. A new study from the Centre for Addiction and Mental Health (CAMH) debunks this cultural myth, and offers clinicians valuable insight […]
Gene Variations In Diverse Patient Populations Determine Who Responds Best To An Antidepressant
Tuesday, July 15th, 2008A new Mayo Clinic study shows that variations in the serotonin transporter gene could explain why some people with depression respond better than others to treatment with citalopram (Celexa), an antidepressant medication. The study, in the current issue of the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, examined the serotonin […]
TheraGenetics Licenses Intellectual Property Related To Predicting Patient Response To Antidepressant Therapy
Monday, July 14th, 2008TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system (CNS) disorders, announced that it has completed an agreement with the Centre for
« Previous Entries Next Entries »